Freeline Therapeutics Holdings plc Basic Shares Outstanding (Weighted Average)
Freeline Therapeutics Holdings plc reported Basic Shares Outstanding (Weighted Average) of 65.22 million shares for the 9-month period ending 2023-09-30, per its 6-K filed 2023-12-01.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2023-12-01
- Freeline Therapeutics Holdings plc weighted average number of shares outstanding, basic for the quarter ending 2023-09-30 was 65.37M shares, a 0.60% increase year-over-year.
- Freeline Therapeutics Holdings plc weighted average number of shares outstanding, basic for the quarter ending 2023-06-30 was 65.15M shares, a 0.96% increase year-over-year.
- Freeline Therapeutics Holdings plc weighted average number of shares outstanding, basic for the quarter ending 2023-03-31 was 65.13M shares, a 52.73% increase year-over-year.
- Freeline Therapeutics Holdings plc weighted average number of shares outstanding, basic for the quarter ending 2022-12-31 was 64.93M shares, a 81.59% increase year-over-year.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2023-09-30 | 65.37M shares derived: 6-K 9 month − 6-K 6 month · filed 2023-12-01 | 65.26M shares derived: average of 2 quarters · filed 2023-12-01 | 65.22M shares 6-K · filed 2023-12-01 | 65.15M shares derived: average of 4 quarters · filed 2023-12-01 |
| 2023-06-30 | 65.15M shares derived: 6-K 6 month − 6-K 3 month · filed 2023-08-15 | 65.14M shares 6-K · filed 2023-08-15 | 65.07M shares derived: average of 3 quarters · filed 2023-08-15 | 65.05M shares derived: average of 4 quarters · filed 2023-12-01 |
| 2023-03-31 | 65.13M shares 6-K · filed 2023-05-30 | 65.03M shares derived: average of 2 quarters · filed 2023-05-30 | 65.01M shares derived: average of 3 quarters · filed 2023-12-01 | 64.89M shares derived: average of 4 quarters · filed 2023-12-01 |
| 2022-12-31 | 64.93M shares derived: 20-F 12 month − 6-K 9 month · filed 2023-04-04 | 64.96M shares derived: average of 2 quarters · filed 2023-12-01 | 64.81M shares derived: average of 3 quarters · filed 2023-12-01 | 59.27M shares 20-F · filed 2023-04-04 |
| 2022-09-30 | 64.98M shares derived: 6-K 9 month − 6-K 6 month · filed 2023-12-01 | 64.76M shares derived: average of 2 quarters · filed 2023-12-01 | 57.38M shares 6-K · filed 2023-12-01 | 51.98M shares derived: average of 4 quarters · filed 2023-12-01 |
| 2022-06-30 | 64.53M shares derived: 6-K 6 month − 6-K 3 month · filed 2023-08-15 | 53.59M shares 6-K · filed 2023-08-15 | 47.64M shares derived: average of 3 quarters · filed 2023-08-15 | 44.66M shares derived: average of 4 quarters · filed 2023-08-15 |
| 2022-03-31 | 42.64M shares 6-K · filed 2023-05-30 | 39.20M shares derived: average of 2 quarters · filed 2023-05-30 | 38.04M shares derived: average of 3 quarters · filed 2023-05-30 | |
| 2021-12-31 | 35.76M shares derived: 20-F 12 month − 6-K 9 month · filed 2023-04-04 | 35.74M shares derived: average of 2 quarters · filed 2023-04-04 | 35.70M shares 20-F · filed 2023-04-04 | |
| 2021-09-30 | 35.72M shares derived: 6-K 9 month − 6-K 6 month · filed 2022-11-15 | 35.69M shares 6-K · filed 2022-11-15 | ||
| 2021-06-30 | 35.67M shares 6-K · filed 2022-08-09 | |||
| 2020-12-31 | 14.15M shares 20-F · filed 2023-04-04 |